Andrew White has a general corporate practice, with an emphasis on negotiating and documenting complex corporate and commercial transactions, including mergers and acquisitions and equity investments. As a significant part of his practice, he represents both corporate and private equity buyers and sellers in a variety of merger and acquisition transactions. In addition, he assists several institutional growth equity and venture capital firms in their seed capital and early and late-stage financings, including control transactions, and has handled fund formation matters.

Andrew serves as counsel to emerging growth, middle-market and established companies, both public and private, in a variety of fields. His significant corporate clients include BMW of North America, including its investment affiliate BMW iVentures; Novartis Vaccines and Diagnostics and Waters Corporation, a public life sciences company. Significant equity capital clients include Equity Resource Investments; GE Capital Equity Group; Guggenheim Partners; Mediphase Venture Partners; Sandbridge Capital; Spring Lake Equity Partners; and Tudor Growth Equity.

Before joining the firm, Andrew worked on Wall Street, serving as a managing director for Credit Suisse.